Sulforaphane

Mechanism of action

Main mechanism: activation of the Keap1–Nrf2 pathway. Sulforaphane is an electrophile that modifies cysteine residues on Keap1, reducing Nrf2 degradation and promoting its nuclear translocation. Nrf2 binds to AREs (Antioxidant Response Elements), inducing cytoprotective genes (e.g. NQO1, HO-1/HMOX1, GCLC/GCLM for glutathione synthesis, GST). Additional mechanisms: (1) modulation of NF-κB and pro-inflammatory signaling, with possible reduction of cytokines in some contexts; (2) epigenetic effects reported in preclinical models (HDAC inhibition, DNMT modulation) with potential impact on gene expression; (3) support for proteostasis and stress response (e.g. heat shock response) in models; (4) possible influence on glucose and lipid metabolism through reduction of oxidative/inflammatory stress and modulation of cellular pathways (clinical evidence variable).

Supported benefits

• Induction of phase II enzymes and biomarkers of endogenous antioxidant response (e.g. increased NQO1/HO-1 or capacity for conjugation and excretion of certain xenobiotics in controlled studies) (strong)
• Improvement in some metabolic biomarkers in subgroups (e.g. fasting glucose, HbA1c, or insulin resistance in people with metabolic alterations), with non-uniform results across studies and formulations (moderate)
• Reduction in some inflammatory/oxidative markers (e.g. CRP, oxidative stress) in specific populations or experimental contexts; high heterogeneity (limited)
• Support for “healthy aging” pathways (cellular stress resilience, protection against oxidative damage) as a biological rationale; clinical translation to longevity outcomes not demonstrated (emerging)

Safety & side effects

• Gastrointestinal disturbances (nausea, bloating, cramps, diarrhea), more likely at higher doses or in sensitive individuals
• Headache or a sensation of “flushing” reported occasionally
• Possible transient changes in thyroid markers in contexts of high cruciferous vegetable intake (especially with low iodine intake), although data on isolated sulforaphane are limited

FAQ

Are sulforaphane and glucoraphanin the same thing?

No. Glucoraphanin is the precursor (a glucosinolate) present in the plant; sulforaphane is the active product formed when glucoraphanin is converted by myrosinase (from the plant or the microbiota).

Why are study results so variable?

Because the following vary: (1) the form used (free sulforaphane vs. glucoraphanin), (2) the presence or absence of active myrosinase, (3) the matrix (food vs. extract), (4) the individual microbiota, (5) the population studied and the endpoints measured.

Is it correct to consider it an “antioxidant”?

Strictly speaking, it is not a classic radical scavenger like vitamins C/E. It acts mainly by inducing endogenous antioxidant systems through Nrf2, that is, by enhancing the body’s internal capacity to manage oxidative stress.

Is there evidence that it increases longevity in humans?

There is no clinical evidence that sulforaphane increases human longevity. There is a biological rationale and data on biomarkers and cellular mechanisms associated with stress resilience, but “hard” longevity outcomes have not been demonstrated.

Does cooking broccoli reduce sulforaphane?

Intense cooking can inactivate myrosinase, reducing the formation of sulforaphane from glucoraphanin. Gentler methods or consuming a portion raw may favor conversion.